NSC |
Compound |
Enrichment |
Correlation |
NSC 287459 |
Cytarabine AY |
0.00204446620781764 |
0.42433119 |
NSC 715223 |
Null |
0.00204446620781764 |
0.3601141 |
NSC 728856 |
5,6-Dihydro-6-[3-(3-imidazolylpropyl)amino-1-propyl]-5,11-di oxo-11H-indeno[1,2-c]isoquinoline dihdrochloride |
0.00204446620781765 |
0.52622532 |
NSC 731589 |
Null |
0.00204446620781765 |
0.33408467 |
NSC 733882 |
6-(3-Azidopropyl)-5,6-dihydro-9-methoxy-3-nitro-5,11-dioxo-1 1H-indeno[1,2-c]isoquinoline |
0.00204446620781765 |
0.32133045 |
NSC 745689 |
3-Cyano-8-chloro-4-imino-2-methyl thio pyrimido[2,1-b]benzothiazole |
0.00204446620781765 |
-0.1880587 |
NSC 753221 |
3-Hydroxy-10-fluoro-5.6-dihydro-6-imino-isoindolo[2,1a]quinoxaline |
0.00204446620781765 |
0.28148948 |
NSC 80103 |
2,3-Butanediol, 1,4-bis(2-methyl-1-aziridinyl)- (8CI) |
0.00204446620781765 |
0.31785749 |
NSC 128687 |
6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidine-2-methanol, 2,3,3a,9a-tetrahydro-6-imino-3-(phosphonooxy)-, (2R-(2.alpha.,3.beta.,3a.beta.,9a.beta.))- (9CI) |
0.00234598979824212 |
0.41468796 |
NSC 134725 |
K-33 |
0.00234598979824212 |
0.39350654 |